Diaphorina citri psyllid: psy6936


Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030--
MDQITVKEVKILETANDIQERREQVLNRYADFKSEARSKREKLEDSRRFQYFKRDADELESWIYEKLQAASDESYKETTNLQAKIQKHQAFEAEVAAHSNAIVVLDNTGKEMINQNHFASEVIRKRLEELHRLWELLLSKLAEKGMKLQQALVLVQFIRQCDEVMFWINDKEAFVTADEFGADLEHVEVLQRKFDEFQKDMASQEYRVTEVNQLADKLVLEGHPERETIVRRKEELSEAWMRLKQLALMRQEKLFGAHEIQRFNRDADETVAWIAEKDAVLSSDEYGRDLASVQTLQRKHEGVERDLAALEDKVSTLGAEADRLCGIHSDHGDQIQAKRAEIVEYWERLTGKAKGRKQKLDESYYLHRFLADYRDLISWVSDMKAIISADELAKDVAGAEALLERHQEHKGEIDAREDSFRGTADAGQSLLDRNHYAADDIREKLRNLENDKTHLLTLWEERRILYEQCMDLQLFYRDTEQADTWMAKQEAFLSNEDLGDSLDSVEALIKKHEDFEKSLAAQEEKIKALDEFATKLIEGQHYAADDVAQRRDLLLKRRAGLLEKSARRRAILEDSYKFQQFEEIVEYWERLTGKAKGRKQKLDESYYLHRFLADYRDLISWVSDMKAIISADELAKDVAGAEALLERHQEHKGEIDAREDSFRGTADAGQSLLDRNHYAADDIREKLRNLENDKTHLLTLWEERRILYEQCMDLQLFYRDTEQADTWMAKQEAFLSNEDLGDSLDSVEALIKKHEDFEKSLAAQEEKIKALDDLLKVNTMQIKALDEFATKLIEGQHYAADDVAQRRDLLLKRRAGLLEKSARRRAILEDSYKFQQFERDCDETKSWVTEKLKFANDDNYLDPTNLNGKVQKHQNFEQELNANKTRMDEITSTGQELLEANHYASDKIRQRMEQIVHLWESLATATEKKGNKLQEASQQQGFNRTIEDIELWLSEIEGQLMSEDYGKDLTSVQNLQKKHALLEADVASHLDRIESVKAATEQFLERGHFDADNIKAKQAAMCERYENLQRPI
ccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHccc
*********************REQVLNRYADFKSEARSKREKLEDSRRFQYFKRDADELESWIYEKLQ****************IQKHQAFEAEVAAHSNAIVVLDNTGKEMINQNHFASEVIRKRLEELHRLWELLLSKLAEKGMKLQQALVLVQFIRQCDEVMFWINDKEAFVTADEFGADLEHVEVLQRKFDEFQKDMASQEYRVTEVNQLADKLVLEGH****TIVRRKEELSEAWMRLKQLALMRQEKLFGAHEIQRFNRDADETVAWIAEKDAVLSSDEYGRDL*****LQRKHEGVERDLAALEDKVSTLGAEADRLCGIHSDHGDQIQAKRAEIVEYWERLTGKAKGRKQKLDESYYLHRFLADYRDLISWVSDMKAIISADELAKDVAGA****ERHQEHKGEIDAREDSFRGTADAGQ*******YAADDIREKLRNLENDKTHLLTLWEERRILYEQCMDLQLFYRDTEQADTWMAKQEAFLS*************LIKKHEDFEKSLAAQEEKIKALDEFATKLIEGQHYAADDVAQRRDLLLKRRAGLLEKSARRRAILEDSYKFQQFEEIVEYWERLTGKAKGRKQKLDESYYLHRFLADYRDLISWVSDMKAIISADELAKDVAGAEALLERHQEHKGEIDAREDSFRGTADAGQ*******YAADDIREKLRNLENDKTHLLTLWEERRILYEQCMDLQLFYRDTEQADTWMAKQEAFLS***********EALIKKHEDFEKSLAAQEEKIKALDDLLKVNTMQIKALDEFATKLIEGQHYAADDVAQRRDLLLKRRAGLLEKSARRRAILEDSYKFQQFERDCDETKSWVTEKLKFANDDNYL********VQKHQNFEQELNANKTRMDEITSTGQE***********IRQRMEQIVHLWESLATATEKKGNKLQEASQQQGFNRTIEDIELWLSEIEGQLMSEDYGKDLTSVQNLQKKHALLEADVASHLDRIESVKAATEQFLERGHFDADNIKAKQAAMCERYENLQRPI
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MDQITVKEVKILETxxxxxxxxxxxxxxxxxxxxxARSKREKLEDSRRFQYFKRDADELESWIYEKLQAASDESYKETTNLQAKIQKHQAFEAEVAAHSNAIVVLDNTGKEMINQNHFASEVIRKRLEELHRLWELLLSKLAEKGMKLQQALVLVQFIRQCDEVMFWINDKEAFVTADEFGADLEHVEVLQRKFDEFQKDMASQEYRVTEVNQLADKLVLEGHPERETIVRRKEELSEAWMRLKQLALMRQEKLFGAHEIQRFNRDADETVAWIAEKDAVLSSDEYGRDLASxxxxxxxxxxxxxxxxxxxxxxxxxxxxADRLCGIHSDHGDQIQAKRAEIVEYWERLTGKAKGRKQKLDESYYLHRFLADYRDLISWVSDMKAIISxxxxxxxxxxxxxxxxxxxxxKGEIDAREDSFRGTADAGQSLLDRNHYAxxxxxxxxxxxxxxxxxxxxxWEERRILYEQCMDLQLFYRDTEQADTWMAKQEAFLSNEDLGDSLDSxxxxxxxxxxxxxxxxxxxxxIKALDEFATKLIEGQHYAADDVAQRRDLLLKRRAGLLEKSARRRAILEDSYKFQQFEEIVEYWERLTGKAKGRKQKLDESYYLHRFLADYRDLISWVSDMKAIISxxxxxxxxxxxxxxxxxxxxxKGEIDAREDSFRGTADAGQSLLDRNHYAxxxxxxxxxxxxxxxxxxxxxWEERRILYEQCMDLQLFYRDTEQADTWMAKQEAFLSNEDLGDSLDSxxxxxxxxxxxxxxxxxxxxxxxxxxxxLKVNTMQIKALDEFATKLIEGQHYAADDVAQRRDLLLKRRAGLLEKSARRRAILEDSYKFQQFERDCDETKSWVTEKLKFANDDNYLDPTNLNGKVQKHQNFEQELNANKTRMDEITSTGQELLEANHYASDKIRQRMEQIVHLWESLATATEKKGNKLQEASQQQGFNRTIEDIELWLSEIEGQLMSEDYGKDLTSxxxxxxxxxxxxxxxxxxxxxIESVKAATEQFLERGHFDADNIKAKQAAMCERYENLQRPI

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Spectrin alpha chain Spectrin is the major constituent of the cytoskeletal network underlying the erythrocyte plasma membrane. It associates with band 4.1 and actin to form the cytoskeletal superstructure of the erythrocyte plasma membrane. Essential for larval survival and development. Stabilizes cell to cell interactions that are critical for the maintenance of cell shape and subcellular organization within embryonic tissues. Lva and spectrin may form a Golgi-based scaffold that mediates interaction of Golgi bodies with microtubules and facilitates Golgi-derived membrane secretion required for the formation of furrows during cellularization.confidentP13395

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0048790 [BP]maintenance of presynaptic active zone structureprobableGO:0050808, GO:0043954, GO:0009987, GO:0016043, GO:0044763, GO:0071840, GO:0008150, GO:0044699
GO:0005794 [CC]Golgi apparatusprobableGO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0016323 [CC]basolateral plasma membraneprobableGO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0045169 [CC]fusomeprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0031594 [CC]neuromuscular junctionprobableGO:0005575, GO:0045202
GO:0005811 [CC]lipid particleprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0008017 [MF]microtubule bindingprobableGO:0015631, GO:0003674, GO:0005488, GO:0005515, GO:0008092
GO:0030707 [BP]ovarian follicle cell developmentprobableGO:0048610, GO:0030154, GO:0048468, GO:0019953, GO:0007292, GO:0007276, GO:0000003, GO:0048869, GO:0044699, GO:0048477, GO:0032502, GO:0032501, GO:0048609, GO:0032504, GO:0009987, GO:0044767, GO:0022414, GO:0044763, GO:0022412, GO:0044702, GO:0003006, GO:0048856, GO:0008150
GO:0045478 [BP]fusome organizationprobableGO:0006996, GO:0009987, GO:0016043, GO:0044763, GO:0044699, GO:0008150, GO:0071840
GO:0032437 [CC]cuticular plateprobableGO:0005856, GO:0005737, GO:0043228, GO:0015629, GO:0043232, GO:0030863, GO:0044464, GO:0071944, GO:0043229, GO:0005623, GO:0030864, GO:0044446, GO:0044444, GO:0044430, GO:0005938, GO:0005575, GO:0044424, GO:0005622, GO:0043226, GO:0044448, GO:0044422
GO:0016199 [BP]axon midline choice point recognitionprobableGO:0008037, GO:0030030, GO:0030154, GO:0048468, GO:0031175, GO:0007411, GO:0009653, GO:0007275, GO:0044699, GO:0000904, GO:0000902, GO:0042330, GO:0048869, GO:0016043, GO:0032989, GO:0071840, GO:0048666, GO:0048667, GO:0032501, GO:0006935, GO:0030182, GO:0009987, GO:0008038, GO:0044767, GO:0044763, GO:0007409, GO:0048731, GO:0042221, GO:0022008, GO:0032990, GO:0048858, GO:0040011, GO:0048699, GO:0009605, GO:0044707, GO:0050896, GO:0048856, GO:0007399, GO:0016198, GO:0032502, GO:0048812, GO:0008150
GO:0030727 [BP]germarium-derived female germ-line cyst formationprobableGO:0048610, GO:0030154, GO:0048468, GO:0019953, GO:0007292, GO:0007293, GO:0009653, GO:0044699, GO:0000003, GO:0048869, GO:0007276, GO:0048477, GO:0048646, GO:0032502, GO:0032501, GO:0048609, GO:0032504, GO:0008283, GO:0009987, GO:0007281, GO:0022414, GO:0008150, GO:0022412, GO:0048134, GO:0048135, GO:0044767, GO:0044702, GO:0003006, GO:0048856, GO:0044763
GO:0030721 [BP]spectrosome organizationprobableGO:0006996, GO:0009987, GO:0016043, GO:0044763, GO:0044699, GO:0008150, GO:0071840
GO:0030054 [CC]cell junctionprobableGO:0005575
GO:0007009 [BP]plasma membrane organizationprobableGO:0016044, GO:0009987, GO:0016043, GO:0061024, GO:0044763, GO:0071840, GO:0008150, GO:0044699
GO:0008302 [BP]female germline ring canal formation, actin assemblyprobableGO:0048610, GO:0043933, GO:0006810, GO:0019953, GO:0030036, GO:0007300, GO:0007301, GO:0007292, GO:0009653, GO:0044699, GO:0022414, GO:0030029, GO:0071822, GO:0030725, GO:0071840, GO:0016043, GO:0007276, GO:0043063, GO:0043062, GO:0048477, GO:0048646, GO:0032502, GO:0032501, GO:0048609, GO:0032504, GO:0009987, GO:0044767, GO:0003006, GO:0044765, GO:0008150, GO:0022412, GO:0051234, GO:0051179, GO:0000003, GO:0006996, GO:0007015, GO:0044702, GO:0007010, GO:0007293, GO:0048856, GO:0044763
GO:0007308 [BP]oocyte constructionprobableGO:0048610, GO:0009994, GO:0030154, GO:0048468, GO:0007569, GO:0007292, GO:0010259, GO:0007276, GO:0000003, GO:0048869, GO:0044699, GO:0048477, GO:0032502, GO:0048599, GO:0032501, GO:0048609, GO:0032504, GO:0009987, GO:0019953, GO:0007281, GO:0022414, GO:0044763, GO:0022412, GO:0044767, GO:0044702, GO:0003006, GO:0048856, GO:0008150
GO:0007274 [BP]neuromuscular synaptic transmissionprobableGO:0044700, GO:0019226, GO:0032501, GO:0044707, GO:0035637, GO:0050877, GO:0009987, GO:0008150, GO:0044763, GO:0023052, GO:0007268, GO:0007267, GO:0007154, GO:0044699, GO:0003008
GO:0007026 [BP]negative regulation of microtubule depolymerizationprobableGO:0031110, GO:0031111, GO:0031114, GO:0033043, GO:1901879, GO:0051129, GO:0051128, GO:0043244, GO:0032886, GO:0050789, GO:0044699, GO:0043242, GO:0051494, GO:0051493, GO:0065007, GO:0048519, GO:0009987, GO:1901880, GO:0044763, GO:0050794, GO:0010639, GO:0008150, GO:0070507, GO:0048523
GO:0043234 [CC]protein complexprobableGO:0005575, GO:0032991
GO:0042062 [BP]long-term strengthening of neuromuscular junctionprobableGO:0048638, GO:0019226, GO:0035637, GO:0050803, GO:0008582, GO:0050807, GO:0050806, GO:0050804, GO:0023056, GO:0032501, GO:0048634, GO:0051147, GO:0023051, GO:0010647, GO:0010646, GO:0050789, GO:0044699, GO:0044057, GO:0023052, GO:0040008, GO:0060284, GO:0065007, GO:0048518, GO:0048641, GO:0065008, GO:0051971, GO:1901861, GO:0016202, GO:0009987, GO:0050793, GO:0050877, GO:0048742, GO:0050794, GO:0051153, GO:0045595, GO:0008150, GO:0051239, GO:0007268, GO:0007267, GO:0007154, GO:0051128, GO:0003008, GO:0044700, GO:0044707, GO:0031644, GO:0031646, GO:0051963, GO:0044087, GO:0051960, GO:2000026, GO:0044763, GO:0051969, GO:0051240, GO:0048522
GO:0016328 [CC]lateral plasma membraneprobableGO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0031672 [CC]A bandprobableGO:0005737, GO:0005575, GO:0043232, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0030016, GO:0030017, GO:0044444, GO:0043228, GO:0043292, GO:0044424, GO:0043226, GO:0044422, GO:0044449
GO:0031674 [CC]I bandprobableGO:0005737, GO:0005575, GO:0043232, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0030016, GO:0030017, GO:0044444, GO:0043228, GO:0043292, GO:0044424, GO:0043226, GO:0044422, GO:0044449
GO:0030424 [CC]axonprobableGO:0044464, GO:0005623, GO:0005575, GO:0097458, GO:0043005, GO:0042995
GO:0007417 [BP]central nervous system developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0007399, GO:0048856, GO:0008150, GO:0048731, GO:0007275, GO:0044699

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!


Spatial Structural Prediction

Structural Models Based on Templates

Template: 1U4Q, chain A
Confidence level:very confident
Coverage over the Query: 48-362
View the alignment between query and template
View the model in PyMOL
Template: 1U4Q, chain A
Confidence level:very confident
Coverage over the Query: 259-574
View the alignment between query and template
View the model in PyMOL
Template: 3FB2, chain A
Confidence level:very confident
Coverage over the Query: 604-735,755-771,786-820
View the alignment between query and template
View the model in PyMOL
Template: 3F31, chain A
Confidence level:very confident
Coverage over the Query: 14-149
View the alignment between query and template
View the model in PyMOL
Template: 3F31, chain A
Confidence level:very confident
Coverage over the Query: 799-934
View the alignment between query and template
View the model in PyMOL
Template: 3PE0, chain A
Confidence level:very confident
Coverage over the Query: 831-1009
View the alignment between query and template
View the model in PyMOL
Template: 1AJ3, chain A
Confidence level:probable
Coverage over the Query: 261-358
View the alignment between query and template
View the model in PyMOL